Counterfeit Drug Ring Repackaging Fake Medications Discovered in Karnataka Farmhouse

Discarded medical waste discovered near an agricultural strip along the Bengaluru-Mysuru expressway led law enforcement officers to a clandestine counterfeit drug manufacturing and repackaging operation. Operating out of a private farmhouse on the outskirts of C.K. Tandya village in South Bengaluru district, previously known as Ramanagara, the illicit network allegedly supplied fraudulent pharmaceuticals to clinics and hospitals across state lines. Investigators stated that the fake medicines routinely reached vulnerable patients undergoing treatment for critical conditions, including cancer. Local laborers first flagged the suspicious accumulation of discarded medical items on farmland in mid-August. Subsequent police observations revealed frequent visits by individuals on unnumbered scooters alongside regular deliveries managed through standard courier and e-commerce logistics channels.

The clandestine operation was uncovered after agricultural workers noticed unusual waste discarded near the expressway. The secluded farmhouse had drawn scrutiny from villagers who observed steady foot traffic and commercial deliveries without proper local registration plates on transport vehicles. Police teams moving in on the facility identified extensive material used for re-labelling and repackaging commercial pharmaceuticals. Authorities noted that the counterfeit supply chain bypassed standard regulatory checks, routing fake formulations into clinical settings where patients relied on uncompromised therapeutic doses. The distribution network extended beyond local borders into an inter-state syndicate, though specific distribution volumes and financial trails remain under active investigation by state authorities.

The distribution of unverified medications intended for severe illnesses highlights persistent vulnerabilities in medical supply chains. Pharmaceutical re-labelling in India is governed by the Drugs and Cosmetics Act, 1940, and its Rules, requiring strict conditions, re-testing, and approval. Medical waste disposal is governed by the Bio-Medical Waste Management Rules, 2016, under the Environment (Protection) Act, 1986, which mandates segregation, collection, transportation, treatment, and disposal. Law enforcement agencies are examining how the repackaged drugs entered formal healthcare channels, posing immediate health risks to patients receiving oncology treatments and other critical therapies. The CDSCO and state drug control departments are responsible for issuing alerts and providing general guidelines on identifying and reporting counterfeit drugs. Further procedural milestones depend on ongoing forensic analyses of the seized materials and the interrogation of suspects tied to the farmhouse logistics network. Police have continued probing the extent of the inter-state supply routes to identify all commercial entities and medical facilities that received the fraudulent pharmaceutical shipments.